COMMUNIQUÉS West-GlobeNewswire

Invitation to Idorsia's nine-month results 2017 webcast and conference call

16/10/2017 - 17:35

Idorsia will publish its financial results for the first nine months of 2017 on Tuesday 24 October 2017 at 07:00 hrs CEST An investor conference call and webcast will be held to discuss the results on the same day at 15 [...]

LogicBio Therapeutics to Present Preclinical Data at European Society of Gene & Cell Therapy 25th Anniversary Congress in Berlin

16/10/2017 - 15:00

· Company co-founder Professor Adi Barzel, Ph.D., to present new proof-of-concept efficacy data CAMBRIDGE, Massachusetts, Oct. 16, 2017 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc., a gene-therapy company with a [...]

Medtronic Care Management Services and American Well Announce Strategic Partnership to Integrate Telehealth Capabilities

16/10/2017 - 15:00

Partnership Focused on Enabling Care for Chronic, Co-Morbid Patients DUBLIN and BOSTON - October 16, 2017 - Medtronic plc (NYSE:MDT) today announced its Medtronic Care Management Services (MCMS) business and American [...]

Novo Nordisk: FDA posts briefing materials prior to Advisory Committee meeting for semaglutide

16/10/2017 - 14:08

PR171016_Semaglutide-briefing_books_UK This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely [...]

Genedrive PLC: genedrive signs distribution agreement with Sysmex Europe GmbH("Sysmex Europe")

16/10/2017 - 14:00

For release: 16 October 2017 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the [...]

Sanofi and Regeneron Announce Positive Phase 2 Study Results for Dupilumab in Patients With Active Moderate-to-Severe Eosinophilic Esophagitis

16/10/2017 - 14:00

Sanofi and Regeneron Announce Positive Phase 2 Study Results for Dupilumab in Patients With Active Moderate-to-Severe Eosinophilic Esophagitis - Late-breaking oral abstract presented at the World Congress of [...]

Sanofi et Regeneron annoncent les résultats positifs d'une étude de phase 2 du dupilumab dans le traitement de l'oesophagite à éosinophiles modérée à sévère de l'adulte

16/10/2017 - 14:00

Sanofi et Regeneron annoncent les résultats positifs d'une étude de phase 2 du dupilumab dans le traitement de l'oesophagite à éosinophiles modérée à sévère de l'adulte - Présentation spéciale de l'abstract de l'étude [...]

Novo Nordisk A/S - Share repurchase programme

16/10/2017 - 12:39

Bagsværd, Denmark, 16 October 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]

UZA, UZ Gent and AZ Sint-Lucas Gent select Cerner for their new EHR projects

16/10/2017 - 12:00

KANSAS CITY, Mo., Oct. 16, 2017 (GLOBE NEWSWIRE) -- The University Hospitals of Antwerp (UZA), Gent (UZ Gent) and St. Lucas Hospital Gent (AZ Sint-Lucas Gent) have selected Cerner, a global leader in health care [...]

Une avancée majeure dans le marché de la santé en Belgique

16/10/2017 - 12:00

UZA, UZ Gent et AZ Sint-Lucas ont choisi Cerner pour leurs projets de transformation digitale KANSAS CITY, Mo., Oct. 16, 2017 (GLOBE NEWSWIRE) -- Les hôpitaux universitaires d'Anvers (UZA), de Gent (UZ Gent) et l' [...]

Fennec Announces Positive Results From Phase 3 SIOPEL 6 Study on PEDMARK(TM) (sodium thiosulfate) Presented at the 49th Congress of the International Society of Pediatric Oncology (SIOP) 2017 Meeting

16/10/2017 - 12:00

Study met primary endpoint (p=0.0033) Significant reduction in cisplatin induced hearing loss without any evidence of tumour protection in patients with Standard Risk Hepatoblastoma (SR-HB) Company plans to pursue [...]

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

16/10/2017 - 09:00

FIT Biotech Oy Company release October 16, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]

Solon Eiendom ASA : Primary insider notification

16/10/2017 - 08:30

(Oslo, Norway, 13 October 2017) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Skøien AS) has today bought 20 000 shares in Solon Eiendom ASA at a price of NOK 18,7858. Following [...]

CleanSpace Demonstrates Third Generation Respirator Innovation at A+A International Trade Fair

16/10/2017 - 08:01

New, state of the art respirator technology provides smart connectivity and user personalization DUSSELDORF, Germany, Oct. 16, 2017 (GLOBE NEWSWIRE) -- CleanSpace Technology will be introducing their new light-weight, [...]

Nexstim Plc is negotiating an assembly and distribution arrangement in China and a financing arrangement for the financing of its bring-to-market strategy in Europe and the US

16/10/2017 - 08:00

Company announcement, Helsinki, 16 October 2017, at 9:00 am Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), a medical technology company developing and marketing pioneering navigated non-invasive brain [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

16/10/2017 - 07:05

REGULATED INFORMATION GHENT, Belgium, 16 October 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

Probiodrug initiates Phase 2b core program of PQ912 and details further strategy

16/10/2017 - 07:00

Probiodrug initiates Phase 2b core program of PQ912 and details further strategy Company moves seamlessly from finalization of the SAPHIR Phase 2a to next clinical stage Probiodrug takes a double-pronged strategy - [...]

ABLYNX ESTABLISHES SUBSIDIARY IN THE USA AND APPOINTS A GENERAL MANAGER

16/10/2017 - 07:00

GHENT, Belgium, 16 October 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced the establishment of Ablynx, Inc., its subsidiary in the USA, and the appointment of Mr Daniel Schneider as the General [...]

INNATE PHARMA : IPH4102: Final results of the dose-escalation part of the Phase I study

16/10/2017 - 07:00

Final results of the dose-escalation part from the Phase I trial evaluating IPH4102 in patients with advanced cutaneous T-cell lymphomas presented at the EORTC CLTF meeting Marseille, France, October 16, 2017, 7:00 AM [...]